Abstract     Description     Claims     Drawing  

WO2007028574A   [0075] 
EP1760088B1   [0075] 
WO2004067023A   [0087] 
WO03068201A   [0183] 
WO2004084798A   [0183] 
WO0172768A   [0183] 
WO03070752A   [0183] 
US4816567A   [0189]  [0191]  [0195] 
WO9429348A   [0192] 
US4342566A   [0192] 
US4897445A   [0229] 
US4440859A   [0242] 
US4530901A   [0242] 
US4582800A   [0242] 
US4677063A   [0242] 
US4678751A   [0242] 
US4704362A   [0242] 
US4710463A   [0242] 
US4757006A   [0242] 
US4766075A   [0242] 
US4810648A   [0242] 
WO9726328A   [0266] 
WO9518145A   [0276] 
US5849589A   [0279] 
US6406705B1   [0280] 

Pathology and Genetics of the Nervous Systems   [0004] 
Current Protocols in Molecular Biology   [0181] 
Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2   [0182] 
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions   [0183] 
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen   [0183] 
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies   [0183] 
Antibodies: A Laboratory Manual   [0188] 
Antibodies in Human Diagnosis and Therapy   [0199] 
Nucleic Acid Res.   [0211] 
J. Immunol.   [0228] 
Chemical Reagents for Protein Modification   [0232] 
Current Protocols In Protein Science   [0232] 
Methods in Molecular Biology Recombinant Gene Expression, Reviews and Protocols   [0250] 
Proc. Natl. Acad. Sci. USA   [0251] 
Molecular Cloning, A Laboratory Manual   [0251] 
Methods In Yeast Genetics, A Laboratory Manual   [0251] 
Nature   [0251] 
Handbook of Pharmaceutical Excipients   [0285] 
Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres   [0309] 
Nestin expression in embryonic and adult human teeth under normal and pathological conditions   [0318] 
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma   [0318] 
Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Virchows Arch. A Pathol.   [0318] 
Survivin expression correlates with unfavourable prognoses in invasive ductal carcinoma of the breast.   [0318] 
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells   [0318] 
Phenotypic analysis of antigen-specific T lymphocytes   [0318] 
Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis   [0318] 
Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas   [0318] 
Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide   [0318] 
Human fetal hippocampal development: II. The neuronal cytoskeleton   [0318] 
Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.   [0318] 
Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells   [0318] 
EGFR overexpression and radiation response in glioblastoma multiforme   [0318] 
Nestin expression in adult and developing human kidney   [0318] 
Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis.   [0318] 
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody   [0318] 
Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias   [0318] 
Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice   [0318] 
NG2 expression regulates vascular morphology and function in human brain tumours   [0318] 
History of allergies and autoimmune diseases and risk of brain tumors in adults   [0318] 
Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.   [0318] 
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier   [0318] 
Nestin expression in cutaneous melanomas and melanocytic nevi   [0318] 
Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays   [0318] 
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis   [0318] 
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance   [0318] 
Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody   [0318] 
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia   [0318] 
The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients   [0318] 
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction   [0318] 
Quantitatively determined survivin expression levels are of prognostic value in human gliomas   [0318] 
T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl   [0318] 
The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours   [0318] 
NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin   [0318] 
NG2/HMP proteoglycan as a cancer therapeutic target   [0318] 
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling   [0318] 
NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours   [0318] 
The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours   [0318] 
Connective tissues: signalling by tenascins   [0318] 
Blood-brain barrier genomics and cloning of a novel organic anion transporter   [0318] 
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization   [0318] 
Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin   [0318] 
The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation   [0318] 
NrCAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis   [0318] 
Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?   [0318] 
Assembly, transport, and function of MHC class II molecules   [0318] 
Expression of the class VI intermediate filament nestin in human central nervous system tumors.   [0318] 
Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas   [0318] 
TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells   [0318] 
Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma.   [0318] 
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes   [0318] 
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma   [0318] 
Growth factor receptors and their ligands   [0318] 
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity   [0318] 
Expression of the neuroectodermal intermediate filament nestin in human melanomas.   [0318] 
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy   [0318] 
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma   [0318] 
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome   [0318] 
Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C   [0318] 
BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility.   [0318] 
cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma   [0318] 
Adoptive immunotherapy for cancer: building on success   [0318] 
Hsp60 regulation of tumor cell apoptosis   [0318] 
Hedgehog pathway activity in the LADY prostate tumor model.   [0318] 
Genetic approaches identify adult pituitary stem cells   [0318] 
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses   [0318] 
Correlation of B-FABP and GFAP expression in malignant glioma   [0318] 
NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.   [0318] 
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy   [0318] 
Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM)   [0318] 
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo   [0318] 
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria   [0318] 
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association   [0318] 
Immune recognition of a human renal cancer antigen through post-translational protein splicing.   [0318] 
Tenascin-C protein is induced by transforming growth factor-betal but does not correlate with time to tumor progression in high-grade gliomas   [0318] 
Tumor-specific peptide vaccination in newly-diagnosed patients with GBM   [0318] 
Clinical impact and functional aspects of tenascin-C expression during glioma progression   [0318] 
Isolation and characterization of a stem cell population from adult human liver   [0318] 
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma   [0318] 
YKL-40 and matrix metailoproteinase-9 as potential serum biomarkers for patients with high-grade gliomas   [0318] 
Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells   [0318] 
Characterization of GPR56 protein and its suppressed expression in human pancreatic cancer cells   [0318] 
Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis   [0318] 
Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control.   [0318] 
Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a Galpha 12/13 and Rho pathway   [0318] 
Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1.   [0318] 
Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells   [0318] 
Expression of nestin in rat and human glomerular podocytes   [0318] 
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes   [0318] 
BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.   [0318] 
Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study   [0318] 
Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas   [0318] 
Serum YKL-40, a new prognostic biomarker in cancer patients?   [0318] 
Is YKL-40 a new therapeutic target in cancer?   [0318] 
Serum GFAP is a diagnostic marker for glioblastoma multiforme.   [0318] 
Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates   [0318] 
Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.   [0318] 
Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.   [0318] 
FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status   [0318] 
Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors   [0318] 
Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.   [0318] 
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain   [0318] 
Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway.   [0318] 
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen   [0318] 
Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.   [0318] 
Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer   [0318] 
Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis   [0318] 
Nestin is expressed in vascular endothelial cells in the adult human pancreas   [0318] 
Increased expression of stem cell markers in malignant melanoma   [0318] 
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen   [0318] 
Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody.   [0318] 
Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness   [0318] 
Focused microarray analysis of glyco-gene expression in human glioblastomas   [0318] 
Oncostatin M-induced genes in human astrocytomas.   [0318] 
Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration   [0318] 
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.   [0318] 
Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.   [0318] 
Transcriptional response to hypoxia in human tumors   [0318] 
Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling   [0318] 
CNS stem cells express a new class of intermediate filament protein.   [0318] 
Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas   [0318] 
Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors.   [0318] 
Tyrosine kinase expression in pediatric high grade astrocytoma   [0318] 
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.   [0318] 
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme   [0318] 
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells.   [0318] 
Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.   [0318] 
GPR56, a novel secretin-like human G-protein-coupled receptor gene   [0318] 
BRCA1 regulates human mammary stem/progenitor cell fate   [0318] 
CD 127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells   [0318] 
Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules   [0318] 
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma   [0318] 
Identification of tumor precursor cells in the brains of primates with radiation-induced de novo glioblastoma multiforme   [0318] 
Regulation of MHC class II genes: lessons from a disease.   [0318] 
Nestin, PDGFRbeta, CXCL12 and VEGF in Glioma Patients: Different Profiles of (Pro-Angiogenic) Molecule Expression Are Related with Tumor Grade and May Provide Prognostic Information.   [0318] 
Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes.   [0318] 
Analysis of allele-specific contact sites of natural HLA-DR17 ligands   [0318] 
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11   [0318] 
Proliferative status of tumor stem cells may be correlated with malignancy grade of human astrocytomas.   [0318] 
Tumor-specific CD4+ T cells have a major ''post-licensing'' role in CTL mediated anti-tumor immunity.   [0318] 
Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis.   [0318] 
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.   [0318] 
FABP-expressing radial glial cells: the malignant glioma cell of origin?   [0318] 
Tlx, an orphan nuclear receptor, regulates cell numbers and astrocyte development in the developing retina   [0318] 
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma   [0318] 
Olig2 expression, GFAP, p53 and lp loss analysis contribute to glioma subclassification.   [0318] 
Nestin expression by newly formed human blood vessels.   [0318] 
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes.   [0318] 
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory   [0318] 
A listing of human tumor antigens recognized by T cells   [0318] 
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas   [0318] 
Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.   [0318] 
Survivin: role in normal cells and in pathological conditions.   [0318] 
Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors.   [0318] 
Comparison of numerical change of epidermal growth factor receptor gene among pre- and postradiation glioma, and gliosis, and its clinical use.   [0318] 
Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.   [0318] 
The acyl-CoA synthetase ''bubblegum'' (lipidosin): further characterization and role in neuronal fatty acid beta-oxidation.   [0318] 
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma   [0318] 
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma   [0318] 
Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.   [0318] 
Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens   [0318] 
Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends   [0318] 
The intermediate filament nestin is highly expressed in normal human podocytes and podocytes in glomerular disease.   [0318] 
Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.   [0318] 
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.   [0318] 
IMP-3 is a novel progression marker in malignant melanoma.   [0318] 
Notch-1 Regulates Transcription of the Epidermal Growth Factor Receptor Through p53   [0318] 
CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells   [0318] 
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.   [0318] 
Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas.   [0318] 
SYFPEITHI: database for MHC ligands and peptide motifs   [0318] 
MHC Ligands and Peptide Motifs   [0318] 
MHC ligands and peptide motifs: first listing   [0318] 
Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours   [0318] 
YKL-40 protein expression in normal adult human tissues--an immunohistochemical study   [0318] 
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.   [0318] 
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.   [0318] 
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.   [0318] 
Growth promoting signaling by tenascin-C [corrected].   [0318] 
Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.   [0318] 
Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma   [0318] 
Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker   [0318] 
Nestin expression in central nervous system germ cell tumors   [0318] 
Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas.   [0318] 
Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.   [0318] 
Polo-like kinase and survivin are esophageal tumor-specific promoters   [0318] 
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors   [0318] 
Nestin expression in neuroepithelial tumors   [0318] 
Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma   [0318] 
Role of medical history in brain tumour development. Results from the international adult brain tumour study   [0318] 
The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain   [0318] 
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions   [0318] 
Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk.   [0318] 
Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.   [0318] 
EGFR gene amplification--rearrangement in human glioblastomas.   [0318] 
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR   [0318] 
Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors   [0318] 
Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells   [0318] 
GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion   [0318] 
Requirement for CD4 T cell help in generating functional CD8 T cell memory   [0318] 
Podoplanin is expressed in subsets of tumors of the central nervous system.   [0318] 
Notch signaling enhances nestin expression in gliomas   [0318] 
Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.   [0318] 
HC gp-39 gene is upregulated in glioblastomas   [0318] 
Cancer stem cells in nervous system tumors   [0318] 
Identification of a cancer stem cell in human brain tumors.   [0318] 
Identification of human brain tumour initiating cells.   [0318] 
The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy   [0318] 
IMP3 predicts aggressive superficial urothelial carcinoma of the bladder   [0318] 
Association of alpha-dystrobrevin with reorganizing tight junctions   [0318] 
Survivin is an independent prognostic marker for risk stratification of breast cancer patients   [0318] 
Identification of Novel HLA-A*0201-Restricted Epitopes in Recent-Onset Type 1 Diabetic Subjects and Antibody-Positive Relatives.   [0318] 
Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.   [0318] 
Expression of nestin in the podocytes of normal and diseased human kidneys   [0318] 
Nestin as a marker for proliferative endothelium in gliomas.   [0318] 
Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation   [0318] 
Defective CD8 T cell memory following acute infection without CD4 T cell help   [0318] 
Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma   [0318] 
Genetic analysis of human glioblastomas using a genomic microarray system   [0318] 
Developmental change of the nestin-immunoreactive midline raphe glial structure in human brainstem and spinal cord.   [0318] 
Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma.   [0318] 
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma   [0318] 
Identification of neovasculature using nestin in colorectal cancer   [0318] 
Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma   [0318] 
The EGF receptor: structure, regulation and potential role in malignancy.   [0318] 
Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells.   [0318] 
A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins   [0318] 
Nestin expression in normal adrenal gland and adrenocortical tumors.   [0318] 
Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.   [0318] 
Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index   [0318] 
Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis   [0318] 
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma   [0318] 
Distribution of the intermediate filament nestin in the muscularis propria of the human gastrointestinal tract   [0318] 
Fatty acid-binding proteins of nervous tissue   [0318] 
Nestin expression in the cell lines derived from glioblastoma multiforme.   [0318] 
Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas   [0318] 
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion   [0318] 
An antigenic peptide produced by peptide splicing in the proteasome   [0318] 
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides   [0318] 
Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres   [0318] 
Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo   [0318] 
Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells.   [0318] 
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.   [0318] 
Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.   [0318] 
Autoimmune islet destruction in spontaneous type I diabetes is not beta-cell exclusive   [0318] 
CD44 adhesion molecule and neuroglial proteoglycan NG2 as invasive markers of glioma   [0318] 
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma   [0318] 
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis   [0318] 
GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment   [0318] 
Survivin expression predicts early recurrence in early-stage breast cancer   [0318] 
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms   [0318] 
Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas.   [0318] 
KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.   [0318] 
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells   [0318] 
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer?   [0318] 
Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.   [0318] 
Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen   [0318] 
Epidermal growth factor receptor in glioblastoma   [0318] 
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy   [0318] 
Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.   [0318] 
The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma   [0318] 
TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility   [0318] 
Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors   [0318] 
Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells   [0318] 
Suppression of human brain tumor with interference RNA specific for tenascin-C.   [0318] 
Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.   [0318]